Skip to Content
MilliporeSigma
All Photos(5)

Key Documents

MMHEADEZ1

Millipore

Milliflex Oasis® Filtration Head

for use with EZ-Fit® filtration units

Synonym(s):

Milliflex Oasis® Head, Milliflex Oasis® filtration pump head

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41116129
NACRES:
NB.79

Pricing and availability is not currently available.

material

316L stainless steel (ASI)

Quality Level

packaging

pkg of 1 unit

manufacturer/tradename

Milliflex Oasis®

application(s)

bioburden testing
food and beverages
food and beverages
pharmaceutical
water monitoring

compatibility

for use with EZ-Fit® filtration units

shipped in

ambient

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
8.14347901695244767
form

powder

form

powder

form

powder

form

powder

assay

99.99% trace metals basis

assay

≥97.0% (acidimetric)

assay

≥98%

assay

98%

Quality Level

200

Quality Level

200

Quality Level

-

Quality Level

-

impurities

≤150.0 ppm Trace Metal Analysis

impurities

-

impurities

-

impurities

-

mp

293-300 °C (dec.) (lit.)

mp

324 °C (decomposition)

mp

293-300 °C (dec.) (lit.)

mp

293-300 °C (dec.) (lit.)

description

Grade: ultra dry

description

-

description

-

description

-

General description

The Milliflex Oasis® head for EZ-Fit® filtration unit allows the use of EZ-Fit® filtration units with the Milliflex Oasis® filtration pump. The EZ-Fit® filtration unit is a disposable filtration device for bioburden testing and have been designed to ensure optimal microbial recovery. The sterilized, disposable filtration devices streamline the workflow, save time and give highly reliable microbial enumeration results. The Milliflex Oasis® head enables easy attachment of the filtration unit to the Milliflex Oasis® filtration pump.

Application

Milliflex Oasis® Head is an accessory to be used in Milliflex Oasis® filtration pump and finds its application in bioburden testing and water monitoring of beer, bottled water, cosmetics and Pharmaceutical products analysis.

Legal Information

EZ-FIT is a registered trademark of Merck KGaA, Darmstadt, Germany
MILLIFLEX OASIS is a registered trademark of Merck KGaA, Darmstadt, Germany

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Shigeko Yamashiro
Critical reviews in immunology, 32(1), 11-21 (2012-03-21)
Fascin-1 is an actin-bundling protein that shares no homology with other actin-bundling proteins. It is greatly induced upon maturation of dendritic cells (DCs). However, fascin-1 is not expressed in other primary blood cells, including macrophages and neutrophils, indicating a unique
Conxita Jacobs-Cachá et al.
American journal of translational research, 9(9), 4173-4183 (2017-10-06)
Immunosuppression based on calcineurin inhibitors (CNIs) has greatly improved organ transplantation, although subsequent nephrotoxicity significantly hinders treatment success. There are no currently available specific soluble biomarkers for CNI-induced nephrotoxicity and diagnosis relies on renal biopsy, which is costly, invasive and
Felix Kliewe et al.
Scientific reports, 7(1), 9916-9916 (2017-09-01)
Glomerular hypertension causes glomerulosclerosis via the loss of podocytes, which are challenged by increased mechanical load. We have demonstrated that podocytes are mechanosensitive. However, the response of podocytes to mechanical stretching remains incompletely understood. Here we demonstrate that the actin-bundling
Yoshihiro Hayashi et al.
Cancer science, 102(6), 1228-1235 (2011-02-18)
Expression of fascin-1, an actin bundling protein, is a poor prognostic factor in hepatocellular carcinoma (HCC). However, its biological role in HCC cells remains unclear. Using human HCC tissues and cell lines HLE, Hep3B, and Huh7, we investigated whether fascin-1
Sung Pil Hong et al.
Nature communications, 10(1), 3840-3840 (2019-09-04)
Resistant tumours are thought to arise from the action of Darwinian selection on genetically heterogenous cancer cell populations. However, simple clonal selection is inadequate to describe the late relapses often characterising luminal breast cancers treated with endocrine therapy (ET), suggesting

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service